In the joint analysis of BRCA1 and BRCA2 carriers, men in the uppermost PRSER+ quartile had approximately twofold increased breast cancer risk (OR = 2.10, 95% CI = 1.43 to 3.08) compared with men in the lowest quartile (Supplementary Table 6, available online). The gene discussed is BRCA2; the disease is breast cancer.